Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$1.50 USD
-0.10 (-6.25%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $1.58 +0.08 (5.33%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.50 USD
-0.10 (-6.25%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $1.58 +0.08 (5.33%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Zacks News
Will Trinity Biotech Stock Gain From Its Latest Patent Process?
by Zacks Equity Research
TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in its next-gen CGM technology.
Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout
by Zacks Equity Research
Trinity Biotech's (TRIB) focus on CGM as an initial step, utilizing a device with regulatory approval, provides a de-risked entry point in the wearable biosensor technology space.